SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-23-000903
Filing Date
2023-01-30
Accepted
2023-01-30 16:30:33
Documents
1
Period of Report
2023-01-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6385
  Complete submission text file 0000902664-23-000903.txt   8607
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Reporting) CIK: 0001633313 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36500 | Film No.: 23568213

Mailing Address C/O AVORO CAPITAL ADVISORS LLC 110 GREENE STREET, SUITE 800 NEW YORK NY 10012
Business Address
Aghazadeh Behzad (Reporting) CIK: 0001701815 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36500 | Film No.: 23568212